Annexin V Produkte
(Annexin A5 (ANXA5))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte Annexin V Kategorien
Annexin V Antikörper
High quality antibodies with extensive validation data.
Annexin V ELISA Kits
Reliable ELISA kits for a wide range of species.
Annexin V Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene Annexin V Antikörper
- (3)
- (7)
- (6)
- (9)
Empfohlene Annexin V ELISA Kits
- (1)
- (6)
- (1)
- (1)
Empfohlene Annexin V Proteine
- (2)
- (1)
- (1)
Neueste Publikationen zu unseren Annexin V Produkten
: "Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin." in: PLoS ONE, Vol. 16, Issue 1, pp. e0245581, (2021) (PubMed).: "Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons." in: Brain, behavior, and immunity, Vol. 76, pp. 126-138, (2019) (PubMed).
: "Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket." in: Nature communications, Vol. 9, Issue 1, pp. 3845, (2018) (PubMed).
: "Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin." in: Oxidative medicine and cellular longevity, Vol. 2017, pp. 9656719, (2018) (PubMed).
: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." in: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).
: "Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases." in: Annals of the rheumatic diseases, (2015) (PubMed).
: "Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra." in: Annals of the rheumatic diseases, (2015) (PubMed).
: "Safety profile of accelerated corneal cross-linking versus conventional cross-linking: a comparative study on ex vivo-cultured limbal epithelial cells." in: The British journal of ophthalmology, Vol. 99, Issue 2, pp. 272-80, (2015) (PubMed).
: "Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 21, Issue 10, pp. 2348-58, (2015) (PubMed).
: "Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 21, Issue 2, pp. 396-404, (2015) (PubMed).
Synonyme und alternative Namen zu Annexin V
annexin A5 (ANXA5), annexin A5b (anxa5b), annexin A5 (anxa5), Annexin A5 (anxa5), annexin A5 (Anxa5), annexin A5 L homeolog (anxa5.L), anx, anx5, ANX5, Anx5, anxa5, ANX V, cb989, ENX2, enx2, LC5, MGC89158, PP4, R74653, RPRGL3, wu:fa98f06, wu:fj10f10Bezeichner auf Proteinebene für Annexin V
- annexin 5
- annexin A5
- Annexin A5
- annexin A5-like
- CBP-I
- PAP-I
- VAC-alpha
- anchorin CII
- annexin V
- annexin-5
- calphobindin I
- endonexin II
- lipocortin V
- placental anticoagulant protein 4
- placental anticoagulant protein I
- thromboplastin inhibitor
- vascular anticoagulant-alpha
- PP4
- Annexin V
- annexin V (endonexin II)